Clinical Trials Browser

Terminated × Breast Neoplasms × Sunitinib × Clear all

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00905021 2020-07-24

EXTENT

Phase 1/2 Terminated

4 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

NCT00616122 2020-01-13

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

32 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00824538 2018-04-05

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

Phase 2 Terminated

13 enrolled 6 charts

Breast Neoplasms

NCT02074878 2017-08-09

CRIZENT

Phase 1 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00570908 2014-09-18

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Phase 2 Terminated

12 enrolled 7 charts

Brain Neoplasms, Breast Neoplasms

NCT00373113 2012-06-25

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Phase 3 Terminated

482 enrolled 12 charts

Breast Neoplasms

NCT00417885 2010-09-21

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Phase 1/2 Terminated

6 enrolled 6 charts

Breast Neoplasms

NCT00434356 2009-12-03

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

Phase 2 Terminated

46 enrolled 8 charts

Breast Neoplasms